Molecular Pathogenesis of Hepatocellular Carcinoma

Overview

Journal Alcohol Clin Exp Res

Specialty Psychiatry

Date 2011 Feb 10

PMID 21303380

Citations 21

Authors

Helena Cornella

Clara Alsinet

Augusto Villanueva

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is one of the major causes of death among cirrhotic patients, being viral hepatitis and alcohol abuse, the main risk factors for its development. The introduction of highly sophisticated genomic technologies has spurred extensive research on the molecular pathogenesis of this devastating disease. Several signaling cascades have been consistently found dysregulated in HCC (e.g., WNT-β-catenin, PI3K/AKT/MTOR, RAS/MAPK, IGF, HGF/MET, VEGF, EGFR, and PDGF). In addition, there have been numerous molecular classifications proposed for this disease, what provides an additional hint about its genomic complexity. The importance of knowing the molecular drivers of HCC is underscored by the positive results of a molecular targeted agent, sorafenib, able to improve survival in patients with advanced disease. This review will briefly outline key concepts in alcohol-related hepatocarcinogenesis, and provide some insight regarding current trends in translating HCC genomics into clinical management of the disease.

Citing Articles

Angiogenic signaling pathways and anti-angiogenic therapy for cancer.

Liu Z, Chen H, Zheng L, Sun L, Shi L Signal Transduct Target Ther. 2023; 8(1):198.

PMID: 37169756 PMC: 10175505. DOI: 10.1038/s41392-023-01460-1.

A Smart Nano-Theranostic Platform Based on Dual-microRNAs Guided Self-Feedback Tetrahedral Entropy-Driven DNA Circuit.

Yang S, Luo J, Zhang L, Feng L, He Y, Gao X Adv Sci (Weinh). 2023; 10(19):e2301814.

PMID: 37085743 PMC: 10323617. DOI: 10.1002/advs.202301814.

Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy.

Wu Y, Tu C, Shao C BMC Surg. 2021; 21(1):178.

PMID: 33794850 PMC: 8017621. DOI: 10.1186/s12893-021-01180-9.

Hepatocarcinoma Induces a Tumor Necrosis Factor-Dependent Kupffer Cell Death Pathway That Favors Its Proliferation Upon Partial Hepatectomy.

Hastir J, Delbauve S, Larbanoix L, Germanova D, Goyvaerts C, Allard J Front Oncol. 2020; 10:547013.

PMID: 33178579 PMC: 7597592. DOI: 10.3389/fonc.2020.547013.

Isocitrate dehydrogenase 3A, a rate-limiting enzyme of the TCA cycle, promotes hepatocellular carcinoma migration and invasion through regulation of MTA1, a core component of the NuRD complex.

Liu X, Qiao Y, Ting X, Si W Am J Cancer Res. 2020; 10(10):3212-3229.

PMID: 33163266 PMC: 7642667.